Quadruple therapy with ARNI vs quadruple therapy with ACEI on cardiovascular outcomes for heart failure with reduced ejection fraction: a network meta-analysis
Prevalence of cardiac amyloidosis in internal medicine patients with heart failure: PREVAMIC
22 May 2022
HFA Premium Access
Empagliflozin improves cardiovascular and renal outcomes in patients with preserved ejection fraction irrespective of age: insights from the EMPEROR-Preserved trial
21 May 2022
HFA Premium Access
Left Ventricular Pseudoaneurysm after a silent myocardial infarction.